Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 33 Results Clear All
The Colorectal Cancer Alliance has awarded Pelka a $500,000 grant to develop novel immunotherapies that overcome the most common form of colorectal cancer.
Grants News Release Cancer Pelka Lab
A Gladstone team has unearthed new findings about what happens during the minutes and hours after a cell divides, expanding our understanding of human biology—and potentially leading to better medicines.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab
Scientists at Gladstone and UCSF discover how one protein controls the behavior of immune cells, with potential applications for treating cancer and autoimmune conditions.
News Release Research (Publication) Autoimmune Diseases Cancer Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
Drug Discovery World—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, is featured for his innovative work using CRISPR genome editing to develop better cellular therapies for cancer, silencing genes that cause immune cells to become exhausted and activating genes that help them be more effective.
Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing
ABC7 News—Gladstone’s president Deepak Srivastava, and Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explain how scientists are using artificial intelligence to pinpoint the best ways to treat cancer.
Gladstone Experts Cancer Data Science and Biotechnology Pollard Lab Srivastava Lab AI
Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells.
Awards News Release Cancer Eyquem Lab
Two new tools created at Gladstone Institutes allow scientists to study DNA at single-molecule resolution using fewer cells than previously required, with clear applications for cancer and many other diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Genomics Human Genetics
A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies.
News Release Autoimmune Diseases Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Marson Lab Pollard Lab Ye Lab AI CRISPR/Gene Editing
A search for the brightest minds in cancer and AI led Hope and Sanjit Biswas to give in their own backyard.
Donor Stories Cancer Biswas Center for Transformative Computational Cancer Biology Data Science and Biotechnology Pollard Lab AI Big Data
GenomeWeb—The Biswas Family Foundation and the Milken Institute have awarded nearly $14 million in grants to researchers developing artificial intelligence and other computational tools for clinical applications. The money will go to five groups, including one from the Gladstone Institutes that is developing machine-learning models to personalize colorectal and skin cancer diagnosis and treatment.
Grants Cancer Biswas Center for Transformative Computational Cancer Biology Data Science and Biotechnology Pollard Lab AI Big Data
The Biswas Family Foundation and Milken Institute announce funding to establish a center for computational cancer biology at Gladstone Institutes, led by Senior Investigator Katie Pollard.
Grants News Release Cancer Biswas Center for Transformative Computational Cancer Biology Data Science and Biotechnology Pollard Lab AI Big Data
The health and science publication STAT has selected a breakthrough discovery from Gladstone to be part of its annual STAT Madness competition, in which research institutes compete for the title of champion. The winner is deemed the most innovative research institution in the country.
Research (Publication) Cancer Genomic Immunology Doudna Lab CRISPR/Gene Editing
Fierce Biotech—A naturally occurring mutation in T cells that leads to lymphoma can be weaponized to make engineered T-cell therapies more effective against cancer, including melanoma, findings from a new study in mice suggest. The study’s co-leads, dermatologist Jaehyuk Choi and scientist Kole Roybal, have launched a new biotech company called Moonlight Bio to take their findings to the clinic.
Research (Publication) Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Roybal Lab Genomics
Nature—Cancer cells are the ultimate survivors, riddled with mutations that let them thrive when healthy cells would die. These same mutations can boost the ability of game-changing cell therapies to quash cancer, a study in mice shows. “Natural T-cell function isn’t good enough. We need to explore the extremes of T-cell function,” says Kole Roybal, co-author of the new paper.
Research (Publication) Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Roybal Lab Genomics
In a new study that appears in Nature, researchers leveraged the power of a naturally occurring mutation in cancerous T cells to create a more powerful immunotherapy
News Release Research (Publication) Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Roybal Lab
